Screener
Madrigal Pharmaceuticals, Inc. MDGL Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $292,726 | $198,693 |
| Restricted cash | 155 | 5,090 |
| Marketable securities | 546,027 | 784,866 |
| Trade receivables, net | 192,311 | 134,476 |
| Inventory | 99,391 | 74,841 |
| Prepaid expenses and other current assets | 68,570 | 47,804 |
| Total current assets | 1,199,180 | 1,245,770 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s short-term investments?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported short-term investments of $546.03M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s short-term investments decreased by 10.6% year-over-year, from $610.83M to $546.03M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s short-term investments has grown at a 27.8% compound annual growth rate (CAGR), from $230.15M to $784.87M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude